In continuation to letter dated August 04, 2025, Bhagiradha Chemicals & Industries has informed that the Board of Directors of the Company at their meeting held on August 12, 2025 approved the following items: Un-Audited Financial Results (Standalone & Consolidated) as per Ind-AS for the Quarter ended June 30, 2025, as reviewed and recommended by the Audit Committee; Limited Review Report of the Statutory Auditors of the Company on the Un-Audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2025; Statement of deviation(s) or variation(s) in the use of proceeds from the preferential issue of convertible warrants under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30, 2025, as reviewed and recommended by the Audit Committee (Copy enclosed) The meeting of the Board of Directors commenced at 12:00 pm (IST) and concluded at 03:40 pm (IST).
The above information is a part of company’s filings submitted to BSE.
